These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
500 related items for PubMed ID: 30144082
21. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605 [Abstract] [Full Text] [Related]
22. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors. Stolz M, Tinguely C, Fontana S, Niederhauser C. Transfusion; 2014 Nov; 54(11):2961-7. PubMed ID: 24805974 [Abstract] [Full Text] [Related]
23. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country. van de Laar TJ, Marijt-van der Kreek T, Molenaar-de Backer MW, Hogema BM, Zaaijer HL. Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685 [Abstract] [Full Text] [Related]
24. Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples. Arora S, Doda V, Kirtania T. Blood Transfus; 2015 Apr; 13(2):227-32. PubMed ID: 25369612 [Abstract] [Full Text] [Related]
25. Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern China. Ye X, Xiong W, Xu X, Zeng J, Xie H, Li B, He B, Chen L, Mo Q. BMC Infect Dis; 2024 Sep 02; 24(1):909. PubMed ID: 39223540 [Abstract] [Full Text] [Related]
26. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool? Wang L, Chang L, Xie Y, Huang C, Xu L, Qian R, Zhu H, He Y, Li J, Huang H, Li W, Zhang K, Zhang R, Xie J, Sun Y, Li J. Transfusion; 2015 Feb 02; 55(2):395-404. PubMed ID: 25125223 [Abstract] [Full Text] [Related]
27. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay. Tsoi WC, Lelie N, Lin CK. Transfusion; 2013 Oct 02; 53(10 Pt 2):2477-88. PubMed ID: 23521050 [Abstract] [Full Text] [Related]
28. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H, Japanese Red Cross NAT Screening Research Group. Transfusion; 2007 Jul 02; 47(7):1162-71. PubMed ID: 17581150 [Abstract] [Full Text] [Related]
29. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015). Fiedler SA, Oberle D, Chudy M, Scheiblauer H, Henseler O, Halbauer J, Heiden M, Funk M. Vox Sang; 2019 Jul 02; 114(5):443-450. PubMed ID: 31012114 [Abstract] [Full Text] [Related]
30. Significance of HBV NAT Among HBs Antigen-Negative Blood Donors in Saudi Arabia. Alabdallat NG, Bin Dukhyil AAA. Lab Med; 2018 Oct 11; 49(4):342-346. PubMed ID: 29767761 [Abstract] [Full Text] [Related]
31. Occult hepatitis B infection among blood donors from Yaoundé, Cameroon. Fopa D, Candotti D, Tagny CT, Doux C, Mbanya D, Murphy EL, Kenawy HI, El Chenawi F, Laperche S. Blood Transfus; 2019 Nov 11; 17(6):403-408. PubMed ID: 31846605 [Abstract] [Full Text] [Related]
32. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing. Lelie N, Bruhn R, Busch M, Vermeulen M, Tsoi WC, Kleinman S, International NAT Study Group. Transfusion; 2017 Jan 11; 57(1):24-35. PubMed ID: 27673757 [Abstract] [Full Text] [Related]
33. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Blood Transfus; 2017 Jan 11; 15(1):6-12. PubMed ID: 27416568 [Abstract] [Full Text] [Related]
34. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply. Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Transfusion; 2015 Apr 11; 55(4):890-7. PubMed ID: 25363504 [Abstract] [Full Text] [Related]
37. Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors. Gou H, Pan Y, Ge H, Zheng Y, Wu Y, Zeng J, Yang Z, Pan T, Cun W, Zhou G, Fang G, Zhang J, Zhang K, Zhang R, Sun Y, Xie J, Li J, Wang L. Transfusion; 2015 Sep 11; 55(9):2272-81. PubMed ID: 26177670 [Abstract] [Full Text] [Related]
38. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group. Hepatology; 2006 Dec 11; 44(6):1666-74. PubMed ID: 17133474 [Abstract] [Full Text] [Related]
40. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Keechilot CS, Shenoy V, Kumar A, Biswas L, Vijayrajratnam S, Dinesh K, Nair P. Pathog Glob Health; 2016 Feb 11; 110(7-8):287-291. PubMed ID: 27788631 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]